fbpx

Macugen®

What Is Macugen®?

Macugen® is an injectable treatment that can slow the progression of and treat neovascular age-related macular degeneration. Macugen® is an anti-VEGF drug. VEGFs are proteins in the body that create new blood vessels. When the body produces too many VEGFs, it can create an abnormal formation of blood vessels that damage the eyes. VEGFs are one of the common causes of macular degeneration, which is why Macugen® is often used as a treatment for it.

Frequently Asked Questions

Who Is A Good Candidate For The Macugen® Treatment?

Good candidates for the Macugen® treatment are patients who are suffering from wet AMD, a rarer form of macular degeneration that is more likely to cause severe vision loss. This is because this particular form of macular degeneration is most often caused and accelerated by blood vessel formation, which anti-VEGFs can treat.

How Is The Macugen® Treatment Done?

Good candidates for the Macugen® treatment are patients who are suffering from wet AMD, a rarer form of macular degeneration that is more likely to cause severe vision loss. This is because this particular form of macular degeneration is most often caused and accelerated by blood vessel formation, which anti-VEGFs can treat.

What Are The Benefits Of Macugen®?

Macugen® offers a quick injectable treatment for the management of wet AMD, with infrequent dosage requirements providing patients with a flexible treatment experience. The benefits of Macugen® are shown to be effective for up to two years, giving patients long-lasting relief to the symptoms and dangers of macular degeneration.

What Are The Risks Associated With Macugen®?

Macugen® is used less often than other macular degeneration treatments because of its known risks and side effects, which include blurred vision, inflammation, swelling, irritation and spotty vision. However, it is still an approved and effective treatment for the long-term maintenance of wet AMD.

Skip to content